DSCT:TASEIsrael Discount Bank Limited Class A Analysis
Data as of 2026-06-30 - not real-time
ILA 2,960.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Israel Discount Bank is trading below its short‑term moving average, with the short‑term average also under the mid‑term and long‑term averages, confirming a bearish price bias. The relative strength index hovers around the neutral zone, indicating limited momentum, while the MACD histogram is positive, hinting at a modest bullish divergence. Current price sits near the midpoint of a well‑defined support‑resistance corridor, and trading volume has been on an upward trend, suggesting growing interest despite the downtrend. Market sentiment is extremely bullish, as reflected by an “Extreme Greed” reading on the fear‑and‑greed index, which may be inflating short‑term optimism.
Fundamentally, the bank trades at a price‑to‑earnings multiple well below the industry average, and its dividend yield is notably high with a payout ratio under 50%, supporting dividend sustainability. A discounted cash‑flow model places fair value substantially above the market price, implying a sizable upside potential. Volatility is elevated, yet beta is negative, indicating the stock moves opposite to broader market swings. Overall, the combination of attractive valuation, solid dividend, and defensive cash position makes the stock appealing for value‑oriented investors, while heightened regulatory and geographic considerations temper the upside.
Fundamentally, the bank trades at a price‑to‑earnings multiple well below the industry average, and its dividend yield is notably high with a payout ratio under 50%, supporting dividend sustainability. A discounted cash‑flow model places fair value substantially above the market price, implying a sizable upside potential. Volatility is elevated, yet beta is negative, indicating the stock moves opposite to broader market swings. Overall, the combination of attractive valuation, solid dividend, and defensive cash position makes the stock appealing for value‑oriented investors, while heightened regulatory and geographic considerations temper the upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near the middle of its support‑resistance range
- positive MACD histogram despite bearish trend
- increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- substantially undervalued relative to peers
- high dividend yield with moderate payout ratio
- DCF fair value indicating strong upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- solid earnings and profit margins
- stable cash position and low debt‑to‑equity profile
- defensive beta offering downside protection
Key Metrics & Analysis
Financial Health
Revenue Growth-8.00%
Profit Margin32.00%
P/E Ratio9.3
ROE11.22%
ROA0.86%
P/B Ratio1.1
Op. Cash FlowILA1.7B
Industry P/E16.9
Technical Analysis
TrendBearish
RSI47.1
SupportILA 2,806.00
ResistanceILA 3,117.00
MA 20ILA 2,931.50
MA 50ILA 3,122.22
MA 200ILA 3,365.54
MACDBullish
VolumeIncreasing
Fear & Greed Index89.91
Valuation
Fair ValueILA 4,247.09
Target PriceILA 3,798.75
Upside/Downside28.34%
GradeUndervalued
TypeValue
Dividend Yield5.14%
Risk Assessment
Beta-0.35
Volatility27.80%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.